Second National Retrovirus conference: a further report.
Torres
G
G
D000081:Acetamides / Q000627:therapeutic use; D000098:Acetophenones / Q000627:therapeutic use; D000163:Acquired Immunodeficiency Syndrome; D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use; D002423:Cause of Death; D000077404:Cidofovir; D017726:Cytomegalovirus Retinitis / Q000150:complications / Q000188:drug therapy; D003596:Cytosine / Q000031:analogs & derivatives / Q000627:therapeutic use; D005260:Female; D015774:Ganciclovir / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D008297:Male; D063065:Organophosphonates; D009943:Organophosphorus Compounds / Q000627:therapeutic use; D017239:Paclitaxel / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors; D012514:Sarcoma, Kaposi / Q000188:drug therapy / Q000209:etiology; D014376:Tuberculosis / Q000150:complications
D000081:Acetamides; D000098:Acetophenones; D000998:Antiviral Agents; D063065:Organophosphonates; D009943:Organophosphorus Compounds; D018894:Reverse Transcriptase Inhibitors; C080073:loviride; D003596:Cytosine; D000077404:Cidofovir; D017239:Paclitaxel; D015774:Ganciclovir